Trial
NCT02442674
A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
—
Condition
Hyponatremia
Intervention
Tolvaptan
Why stopped
Trial withdrawn due to inability to meet the trial objectives (Pilot).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-31